An antibody-capture enzyme-linked immunosorbent assay (ELISA) 
antibody were tested. Serum samples from 200 healthy blood donors were used for standardization of the assays. The sensitivity of the ELISA varied with time of serum sampling, with a relatively low sensitivity when serum was collected within 3 days after the onset of symptoms (23%; 5 of 22) but good sensitivity when serum was collected later (83%; 20 of 24). The sensitivity was better than that of the CFT. The ELISAs were broadly reactive as concluded from typing of virus isolates that were simultaneously obtained. The assay did, furthermore, detect antibody against poliovirus type 3. Sera that contained rheumatoid factor, antinuclear antibody, or cardiolipin antibody (by the Venereal Disease Research Laboratory test) did not react in this ELISA. Nonspecific reactivity did occur, however, in cases of infectious mononucleosis and in Mycoplasma pneumoniae infection. The enterovirus-specific ELISA is found to be simple to perform, more sensitive than the CFT, and far less laborious than the neutralization test.
Enteroviruses are common pathogens that can cause a variety of symptoms ranging from mild respiratory infection to severe central nervous system disease. Enteroviruses may furthermore play a role in chronic diseases such as postviral fatigue syndrome (1, 12, 14, 37) , chronic myocarditis/dilated cardiomyopathy (8) , polymyositis/dermatomyositis (7, 38) , postpolio syndrome (30) , and insulin-dependent diabetes mellitus (2, 20, 34) . The diagnosis of the acute infection is mainly based on virus isolation and serological tests such as virus neutralization or complement fixation (CF). Virus isolation is not successful in cases of the chronic diseases mentioned above, and a relationship with enteroviruses can be investigated only by molecular techniques (39) or serology. Enteroviruses include 69 serotypes. Hence, a neutralization test is laborious as long as the virus type is not known. CF tests (CFTs) are useful but of limited diagnostic value, particularly in a presumed persistent phase of infection. Enzyme-linked immunosorbent assays (ELISAs) for the diagnosis of enteroviral infections based on either antibody capture (3, 22, 29) or an indirect technique (6, 19) have been described previously. These tests made use of either a single serotype (6) or multiple serotypes (3, 19) as the antigen. Tests for immunoglobulin G (IgG) antibody were shown to be of limited value because of the presence of anamnestic antibody from earlier infections (6) .
We describe an antibody-capture ELISA based on a [28] ) at a multiplicity of infection of 0.5. The cultures were maintained in 150 ml of minimal essential medium with 3% fetal bovine serum, 100 U of penicillin per ml, and 50 ,ug of gentamicin per ml. The roller bottles were incubated at 36°C. Virus was harvested when complete cytopathic effect was observed, usually after 2 to 3 days. Cells were freeze-thawed three times and together with the culture medium firmly shaken with 10% chloroform for 15 min and centrifuged at 2,000 x g for 30 min (18) . The supernatant was centrifuged through a 30% (wt/wt) sucrose cushion at 150,000 x g for 3 h. The pellets were resuspended in a final volume of 6 ml of phosphate-buffered saline (PBS) and heated at 56°C for 60 min in order to denature the virions and convert antigenicity from type specific (N antigen) to group specific (H antigen) (19, 24) . Control antigens were prepared in the same way by using noninfected cell cultures. The protein contents of the viral antigen and the control antigen preparations were determined as described by Lowry et al. (21) . The antigens were conjugated with horseradish peroxidase as described by Wilson and Nakane (35) . The conjugated viral and control antigens were suspended in PBS containing 0.005% mercurothiolate and 2% fetal bovine serum. The labelled antigens were stored in small aliquots at 4°C.
Capture ELISA technique. The antibody-capture ELISAs for detection of enterovirus IgG, IgM, and IgA were carried out essentially as described previously (32, 33 Tween 20) , and shaken dry. Next, 100 ,ul of patient serum diluted at 1:100 in PBS-Tween with 2% fetal bovine serum and 0.005% mercurothiolate (PFT-M) was added and the plates were incubated at 37°C in a humidified atmosphere for 2 h. All sera were tested in duplicate. Plates were washed again four times and shaken dry, and 100p,l of horseradish peroxidase conjugated antigen diluted in PFT-M was added. The optimal dilution of conjugated antigen was determined by block titration and was 1:1,000 for the IgG assay and 1:1,500 for the IgM and IgA assay. After overnight incubation at 4°C, the plates were washed again and 100 ,ul of substrate solution was added. The substrate solution was prepared immediately before use by dissolving 4 mg of orthophenylenediamine per ml in 0.05 M citrate buffer (pH 5.2) and then adding 0.045% hydrogen peroxide (final concentration). The reaction was stopped after exactly 10 min by the addition of 100 p.l of 3 M H2SO4. The A492 was read (Titertek Multiskan; Flow Laboratories, Irvine, United Kingdom). The buffer control was used as a blank. A strongly positive serum sample, a cutoff serum sample, and a negative control serum sample were included in each test. The cutoff was chosen on the assumption that at most 5% of the serum samples from healthy blood donors were reactive. A serum sample was considered positive when the absorbance was at least twice the absorbance of the cutoff serum for IgM and IgA or at least the same as cutoff value for IgG. The ELISA with the control antigen was performed in a similar way.
CFT. The CFT was performed according to the microtiter technique described by Casey (9) . The enterovirus antigen in the CFT consisted of a mixture of antigens including coxsackieviruses Bi to B5 and A9 and echoviruses 4, 6, 9, 14, 24, and 30 (Behringwerke AG, Marburg, Germany). The titer is expressed as the reciprocal of the highest dilution showing 50% hemolysis. The CFT was considered positive when a fourfold increase of antibodies between acute and convalescent sera was found or when the titer was >128.
Neutralization test. Sera from some of the patients were tested for neutralizing antibodies as described by Melnick et al. (25) Enterovirus was isolated either from CSF (n = 9), from a throat swab (n = 2), or from a fecal sample (n = 4). in three cases no infection was documented, and in three cases a noninfectious cause was found. All serum samples from these patients were negative by ELISA and CFT.
For 27 patients, no material for culture was available; thus, only serologic tests were performed. For 21 of these patients, enterovirus-specific serology was negative. In five of these patients there was serologic evidence for other viral infections, namely, by herpes simplex virus (n = 1), parainfluenza virus (n = 3), and respiratory syncytial virus (n = 1). For six patients, serology indicated a past or recent enterovirus infection. Data for four of these patients are presented in Table 2 (patients 22, ELISA with the control antigen, some reactivity was found in the Monospot-positive sera and sera with antibodies against M. pneumoniae. However, reactivity with the control antigen was less prominent than reactivity with the enteroviral antigen. In 2 of 10 Monospot-positive serum samples and in 2 of 10 serum samples containing mycoplasmal antibodies, high titers were found by CFT, suggesting recent enterovirus infection or nonspecific reactivity occurring in CFT as well. All patient sera that were positive by ELISA with the enteroviral antigen were tested with the control antigen as well. None were reactive.
DISCUSSION
The aim of this study was to evaluate the sensitivity and specificity of a coxsackievirus Bl-based antibody-capture ELISA as a simple test with broad reactivity for enteroviruses. It is known that cross-reactive epitopes are located on the empty capsids of enteroviruses. Heating to 56°C converts virions to empty capsids, thereby changing the antigenicity to group-specific reactivity (19, 24, 29) . The present study confirms this broad specificity. During the development of these ELISAs we have made conjugated antigens of the 10 enterovirus types with the highest incidence in The Netherlands. These conjugates have been tested either separately or as antigen mixtures. So far, infections by the following known serotypes have been recognized: echoviruses 6, 7, 9, 11, 14, 19, 25 , and 30; coxsackieviruses Bi, B2, B4, and B5; and poliovirus type 3. A combination of various serotypes pooled with an antigen mixture did not further broaden reactivity for enteroviruses, nor did the use of other serotypes as the antigen (data not shown).
The cutoff values were arbitrarily chosen at the 95% confidence level of reactivity in a population of 200 healthy blood donors. In March (the time of collection of the donor sera), the incidence of acute enterovirus infections is low, but the exact prevalence was not known. This might have influenced the sensitivity and specificity of the tests.
Among the patients with culture-positive enterovirus infections, seven patients were missed by ELISA. In two of these patients (patients 5 and 6), there was also evidence of bacterial infection (Eschenchia coli and Staphylococcus aureus). Therefore, the onset of enteroviral infection is not accurately known for these cases. It may be that the samples were drawn too early to find specific antibodies (patients 9 and 16). Unfortunately, there was no second sample. It may also be that the ELISA was falsely negative. Consistent with this possibility, enteroviral antibodies were detected in patients 5 and 14 by CFT but not by ELISA. Patient 8 suffered from neonatal meningitis and could have had a delayed antibody response, as seen more often with neonatal infections. Enteroviral antibodies were detected by ELISA in CSF from only two of eight patients. This is probably due to the time of sampling. CSF is usually taken at the onset of symptoms, when antibody production is just starting. Antibodies were indeed detected in two of three CSF samples that were taken more than 2 days after onset. Thus, ELISA with CSF may be useful when CSF is taken later than 2 days after onset, comparable to what is found with serum (see below). This has also been described by van Polymerase chain reactions with heart biopsies from this patient, taken at autopsy, were negative for enterovirus.
There is a discrepancy in IgM and IgA responses: nine patients had an IgM response but no IgA response, and three patients had an IgA response but no IgM response. This has been described before (26) , but the reason for this discrepancy is not known.
The sensitivity of the antibody-capture ELISA is good when the outcome of the IgG, IgM, and IgA assays are combined. The sensitivity ranges from 67% in cases of culture-proven enteroviral infections and meningitis (14 of 21 and 10 of 15, respectively) to 86% (6 of 7) in cases of myocarditis, pericarditis, or pleuritis. The sensitivity in the case of poliovirus type 3-specific IgM-positive sera was 100% (15 of 15). The sensitivity is clearly related to the time when serum samples are taken. When serum samples are taken within 3 days after the onset of symptoms, the sensitivity is low (5 of 22 [23%]). When serum is drawn later than 3 days after onset, the sensitivity is good (20 of 24 [83%] ). The CFT with the antigen mixture is less sensitive than the ELISA (44 versus 81%), especially when only one serum sample is available. When the ELISA and CFT were combined, the sensitivity was 88%. This ELISA was found to be as sensitive as an antibody-capture ELISA using different antigens (3, 22) . The sensitivity of the IgM ELISA alone is 58%. When IgM and IgA are combined, the sensitivity increases to 67%. The IgG-capture assay adds another 16% to the sensitivity. The relatively low sensitivity of the IgM and IgA ELISA may be due to the recurrent character of enterovirus infections. Recurrent enteroviral infection with different serotypes causes boosts in responses to common epitopes. This may result in diminished antibody responses of both IgM and IgA. For cytomegalovirus, as an example, it is known that IgM and IgA responses are less prominent or even absent in recurrent infection compared with the primary infection (31, 33) .
Antibody-capture ELISAs have proven to perform excellently with CSF (32) . This is because of the low background levels of nonspecific Igs in CSF as long as the blood-brain barrier is not damaged. This is particularly so for the IgG-capture assay as is illustrated by patients 11 and 12 in our study. It can be envisaged that the IgG-capture ELISA will also perform well in case of high antibody levels (hyperimmunization), as has been reported to occur in persistent infection (2, 7, 37) . This has already been investigated by using poliovirus type-specific ELISAs for postpolio syndrome, with which we did not find evidence for viral persistence (23) . Similar studies are underway for postviral fatigue syndrome, dilated cardiomyopathy, and polymyositis (16) .
As expected, there was no interference by rheumatoid factor. There was little cross-reactivity in sera with antinuclear antibodies and none in sera with positive Venereal Disease Research Laboratory test reactions. Unfortunately, there was significant cross-reactivity with sera that contained heterophile antibodies or M. pneumoniae IgM and IgA antibodies. This is probably due to polyclonal B-cell activation, which is common in Epstein-Barr virus infection and mycoplasmal infection (4, 5, 11) . Cross-reactivity occurred mainly in the IgM ELISA and less in the IgA ELISA. Pitfalls in our assay seem to be similar to those reported by others (13) . The major disadvantage of this test is its crossreactivity with Epstein-Barr virus and M. pneumoniae.
However, the clinical symptoms of these infections are quite different from those of enteroviral infections, and therefore we do not think this will be a major problem in clinical practice. Perhaps the use of synthetic peptides, which has recently been described by Cello et al. (10) , may reduce cross-reactivity. The great advantage of the test we described is that it is simple to perform, more sensitive than the CFT, and far less laborious than the neutralization test.
